article thumbnail

FDA discontinue rare pediatric disease designation program despite increase in RPD approvals

Express Pharma

Despite various peaks and troughs between 2016 to 2024, this period saw an overall positive trend for annual RPD approvals, growing at a compound annual growth rate (CAGR) of 16.2 A peak of RPD approvals came in 2020, with the FDA handing out 55 approvals.

article thumbnail

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

AI models can predict molecular interactions and assist in designing novel compounds tailored to specific therapeutic goals. AI-driven screening methods, such as High-Throughput Screening (HTS), allow researchers to rapidly evaluate large libraries of compounds. 2020 Jan 9;10:1243. Front Genet. doi: 10.3389/fgene.2019.01243.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData

Express Pharma

GlobalDatas report, Endometriosis Market Size and Trend Report, reveals that the endometriosis market size across the seven major markets* (7MM) is expected to achieve a compound annual growth rate of more than 9 per cent during 2020-2030.

article thumbnail

Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss medications

Express Pharma

It results in less weight loss on average than Novo’s newer in-demand Wegovy, which launched in 2020 and was approved in 2022 for adolescents aged 12 and older. Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication kits at $79 per month. regulations.

article thumbnail

Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.

Pharmacy Times

News release. Federal Trade Commission. January 14, 2025. Accessed July 23, 2025. link] Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association, No.18–540. Accessed July 23, 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025. Accessed July 23, 2025.

article thumbnail

Pharmacists Bridge the Gaps in Care Transitions

Pharmacy Times

National Board of Medication Therapy Management; 2020. J Am Coll Clin Pharm. 2024;7(1):8-14.doi:10.1002/jac5.1887 doi:10.1002/jac5.1887 7. Thomas DJ, Tran J, eds. The Medication Therapy Management Pharmacist Reference Book. Burgess LH, Kramer J, Castelein C, et al. HCA Healthc J Med. 2021;2(6):411-421.doi:10.36518/2689-0216.1295

article thumbnail

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Pharmacy Times

million fewer doses were administered in retail and clinical settings than in the prepandemic 2019-2020 season. Additionally, vaccination rates among Medicare beneficiaries 65 years and older reached only 48.3%, and nearly 9.2